Nonmyeloablative bone marrow transplants. 2003

Scott Olszewski
Bone Marrow Transplantation Unit, Tufts-New England Medical Center, Boston, MA, USA. solszewski@gene.com

UI MeSH Term Description Entries
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D016693 Receptors, Antigen, T-Cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules. Antigen Receptors, T-Cell, alpha-beta,T-Cell Receptors alpha-Chain,T-Cell Receptors beta-Chain,T-Cell Receptors, alpha-beta,TcR alpha-beta,Antigen T Cell Receptor, alpha Chain,Antigen T Cell Receptor, beta Chain,Receptors, Antigen, T Cell, alpha beta,T Cell Receptors, alpha beta,T-Cell Receptor alpha-Chain,T-Cell Receptor beta-Chain,T-Cell Receptor, alpha-beta,T Cell Receptor alpha Chain,T Cell Receptor beta Chain,T Cell Receptor, alpha beta,T Cell Receptors alpha Chain,T Cell Receptors beta Chain,TcR alpha beta,alpha-Chain, T-Cell Receptor,alpha-Chain, T-Cell Receptors,alpha-beta T-Cell Receptor,alpha-beta T-Cell Receptors,alpha-beta, TcR,beta-Chain, T-Cell Receptor,beta-Chain, T-Cell Receptors
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D019172 Transplantation Conditioning Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation. Conditioning, Transplantation,Conditionings, Transplantation,Transplantation Conditionings
D020350 Graft vs Tumor Effect Immunological rejection of tumor tissue/cells following bone marrow transplantation. Graft vs Neoplasm Effect,Graft-vs-Neoplasm Effect,Graft-vs-Neoplasm Response,Graft-vs-Tumor Effect,Graft-vs-Tumor Response,Effect, Graft-vs-Neoplasm,Effect, Graft-vs-Tumor,Effects, Graft-vs-Neoplasm,Effects, Graft-vs-Tumor,Graft vs Neoplasm Response,Graft vs Tumor Response,Graft-vs-Neoplasm Effects,Graft-vs-Neoplasm Responses,Graft-vs-Tumor Effects,Graft-vs-Tumor Responses,Response, Graft-vs-Neoplasm,Response, Graft-vs-Tumor,Responses, Graft-vs-Neoplasm,Responses, Graft-vs-Tumor

Related Publications

Scott Olszewski
June 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Scott Olszewski
September 1975, Proceedings of the Royal Society of Medicine,
Scott Olszewski
January 1968, The Journal of the Arkansas Medical Society,
Scott Olszewski
January 1981, Frontiers of radiation therapy and oncology,
Scott Olszewski
February 1990, Pediatrics,
Scott Olszewski
December 1983, The Lamp,
Scott Olszewski
August 2002, BMJ (Clinical research ed.),
Scott Olszewski
February 1958, Medical times,
Scott Olszewski
January 1958, Cancer bulletin (Houston, Tex.),
Scott Olszewski
March 1977, Revue francaise de transfusion et immuno-hematologie,
Copied contents to your clipboard!